Hope springs eternal: are we yet ready for a novel paradigm shift in lipid-lowering therapy in primary prevention?

Authors :: De Buyzere ML
Source :: European journal of preventive cardiology [Eur J Prev Cardiol] 2024 Aug 09; Vol. 31 (10), pp. 1214-1215.
Publication Year :: 2024
Abstract: Competing Interests: Conflict of interest: none declared.

Subjects :: Humans
Cardiovascular Diseases prevention & control
Hypolipidemic Agents therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
Treatment Outcome
Biomarkers blood
Dyslipidemias drug therapy
Dyslipidemias blood
Dyslipidemias diagnosis
Primary Prevention methods

Full Text Access

Tools